MoEngage Raises $180 Million in Extended Series F, Strengthening Its Position in AI-Led Customer Engagement
MoEngage, a global customer engagement platform powering data-driven experiences for consumer brands, has secured an…
Nfinite Nanotechnology, an advanced materials startup based in Waterloo, Ontario, has received up to CAD 3.87 million in funding and advisory support from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). The support aims to accelerate the commercialization of Nfinite’s breakthrough ultra-thin coating platform, enabling high-barrier paper packaging as a sustainable…
Australian medical technology company Ferronova has secured an additional $6 million in funding to accelerate the commercialisation of its nanoparticle-based, image-guided surgery technology aimed at improving the detection of cancer cells during operations and reducing post-surgical recurrence. The latest raise was led by existing investors Uniseed / UniSuper, the South Australian Venture Capital Fund, Artesian…
MoEngage, a global customer engagement platform powering data-driven experiences for consumer brands, has secured an additional $180 million in its Series F round, taking the total raise to $280 million following a $100 million tranche closed in November 2025. The latest funding was led by ChrysCapital and Dragon Funds, with participation from Schroders Capital and…
In a major step forward for AI-powered healthcare innovation, Vitalis Ventures has announced a $15 million strategic investment in Drive Health, the cutting-edge company behind Avery, a groundbreaking AI platform designed to streamline clinical workflows and enhance patient care. With this infusion of capital, which includes an additional funding tranche slated for Q1 2026, the…
Valerie Health, the AI-driven front office for independent provider groups, has raised $30 million in a Series A round led by Redpoint Ventures, bringing its total funding to $39 million. The platform combines AI agents with human-in-the-loop oversight to automate administrative tasks such as referrals, faxes, and scheduling, significantly cutting operational costs while enhancing patient…
Evocative, a global provider of Internet infrastructure, has raised debt financing from a leading international investment firm, complementing ongoing equity support from long-term partner Crestline Investors, Inc.. The capital will support Evocative’s continued expansion into key metro markets and enhance its data center, network, cloud, and bare metal offerings, addressing the rising demand for high-density…
Scylos, a pioneer in stateless endpoint infrastructure, has closed a $3 million oversubscribed seed funding round, led by Galgano Family Investments alongside multiple private investors. The fresh capital is set to accelerate platform development, expand enterprise and public sector pilots, and forge strategic partnerships in security-critical environments. Founder Rich Galgano emphasized that “most endpoint security…
Logpresso, a leading cloud-native Security Information and Event Management (SIEM) specialist, has closed a KRW 16 billion (approximately USD 12 million) Series B funding round, signaling a decisive move toward AI-powered security operations. The investment, supported by both existing backer KB Investment and new institutional participants, aims to accelerate the company’s transition to a next-generation…
HEN Technologies, a pioneer in intelligent fire suppression, has secured $22 million in funding—comprising a $20 million Series A round led by O’Neil Strategic Capital, with participation from NSFO, Tanas Capital, and z21 Ventures, alongside $2 million in venture debt from Silicon Valley Bank. The capital will accelerate the global deployment of Fluid-IQ™, HEN’s predictive…
DNA Nanobots, a biotechnology company pioneering self-assembling nanoscale therapeutics, has secured $3.5 million in funding from a prominent family office, strengthening its financial runway for the next 18 months. The investment marks a key step forward in advancing the company’s non-viral gene delivery platform toward clinical readiness. The funding represents a significant portion of DNA…